DETROIT (AP) — Spencer Torkelson hit a walk-off home run and Riley Greene had two hits, including a two-run homer, to rally the Detroit Tigers to a 5-4 win over the Milwaukee Brewers on Thursday.
He blasted the solo shot to left-center off reliever Abner Uribe (1-1). It was the second straight game that Torkelson homered.
Click to Gallery
Detroit Tigers pitcher Tarik Skubal throws against the Milwaukee Brewers during the fourth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Milwaukee Brewers pitcher Brandon Sproat throws against the Detroit Tigers during the first inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers' Riley Greene (31) celebrates his two-run home run with Kevin McGonigle, right, against the Milwaukee Brewers during the first inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers pitcher Tarik Skubal throws against the Milwaukee Brewers during the fourth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers' Spencer Torkelson reacts to his walk off home run against the Milwaukee Brewers during the ninth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit tied the game at 4 in the eighth inning off Jahmai Jones' second home run of the year.
Reliever Brant Hurter (2-0) shut down Milwaukee in the ninth to set up the Tigers' win.
The Brewers rallied from a 3-1 deficit in the seventh. Blake Perkins tied the game with a double off of Tarik Skubal that scored Gary Sanchez and Luis Matos. David Hamilton then put the Brewers up 4-3 when his single off reliever Tyler Holton brought home Perkins.
Skubal had been dominant early in the game, retiring the first 11 batters and throwing strikes on 24 of his first 26 pitches. He finished allowing four runs on seven hits and striking out five.
Greene gave the Tigers a 2-0 lead in the first with his homer into left-center that scored Kevin McGonigle from third.
William Contreras doubled in the fourth inning and scored when Gary Sanchez drove him in on a double to right.
The Tigers went up 3-1 in the seventh when Dillon Dingler's grounder drove in Colt Keith.
The win pushed the Tigers to an MLB-best 10-2 at home.
Milwaukee: RHP Brandon Woodruff (2-0, 3.42 ERA) is set to face Pirates RHP Paul Skenes (3-1, 3.27) in the opener of a three-game home series on Friday.
Detroit: LHP Framber Valdez (2-1, 3.30) is set to face Reds LHP Andrew Abbott (0-2, 5.84) to begin a three-game series in Cincinnati on Friday.
AP MLB: https://apnews.com/hub/mlb
Detroit Tigers pitcher Tarik Skubal throws against the Milwaukee Brewers during the fourth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Milwaukee Brewers pitcher Brandon Sproat throws against the Detroit Tigers during the first inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers' Riley Greene (31) celebrates his two-run home run with Kevin McGonigle, right, against the Milwaukee Brewers during the first inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers pitcher Tarik Skubal throws against the Milwaukee Brewers during the fourth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
Detroit Tigers' Spencer Torkelson reacts to his walk off home run against the Milwaukee Brewers during the ninth inning of a baseball game Thursday, April 23, 2026, in Detroit. (AP Photo/Paul Sancya)
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative.
The deal involves Regeneron lowering the prices of all its current and future drugs on Medicaid, according to Trump. It also involves selling a cholesterol drug called Praluent for $225 on the White House's discounted drug website TrumpRx, according to the agreement first outlined by NOTUS and confirmed in a White House fact sheet.
The deal comes as the Trump administration has been touting efforts to provide economic relief ahead of November's midterm elections, with Americans saying high costs for health care, gas, groceries and other basic needs are straining their budgets.
It's one of many so-called most-favored-nation deals the Trump administration has made with drug companies to bring U.S. pharmaceutical prices to the same level as other developed nations. Last July, Trump publicly sent letters to executives at 17 major pharmaceutical companies about the issue. Regeneron is the final one of those companies to strike a deal with his administration.
Speaking at the White House on Thursday to announce the deal, Trump touted the discounts on drugs and said, “It should be front page news.” He said voters in this November's midterm elections should reward his party because of the agreements with drugmakers.
“We should win the midterms, but it doesn’t work that way, unfortunately,” Trump said.
Trump also has a notable history with the drugmaker.
During his first term in 2020, when he was hospitalized with COVID-19, he was given a dose of a drug that Regeneron was testing to supply antibodies in order to help his immune system.
After he was released, Trump posted a video of himself standing outside the White House in which he repeatedly lavished praise on Regeneron.
As part of the new deal, Regeneron has also committed to spending $27 billion in research, development and manufacturing in the U.S., according to the White House fact sheet. Trump’s deals have historically offered companies relief from his tariffs if they make such commitments.
Regeneron also announced Thursday that Otarmeni, its new gene therapy for a rare form of congenital hearing loss, had been approved by the Food and Drug Administration and would be made available to clinically eligible individuals in the U.S. at no charge. The therapy received expedited approval from the FDA under the agency’s so-called Commissioner’s National Priority Voucher program.
The program, which was not authorized by Congress, has been under scrutiny from Democrats in Congress for months. House and Senate lawmakers have noted that FDA vouchers have repeatedly gone to companies that agree to pricing concessions sought by the White House.
Even as Trump and his Department of Health and Human Services have touted his drug-pricing deals as transformative, the details of the agreements have so far not been made public.
Pressed by members of Congress to share the contracts this week, Health Secretary Robert F. Kennedy Jr. said his team would share whatever details it could that didn't include proprietary information or trade secrets. Trump and Kennedy have urged Congress to codify the deals into law.
The deals have occasionally run into roadblocks. A centerpiece of the agreements with weight-loss drugmakers Eli Lilly and Novo Nordisk fell apart earlier this week when Medicare delayed implementation of a program for insurers to cover the GLP-1 drugs.
Drug prices for patients in the U.S. can depend on a number of factors, including the competition a treatment faces and insurance coverage. Most people have coverage through work, the individual insurance market or government programs like Medicaid and Medicare, which shield them from much of the cost.
Patients on Medicaid, the state and federally funded program for people with low incomes, already pay a nominal co-payment of a few dollars to fill their prescriptions, but lower prices could help state budgets that fund the programs.
Associated Press writers Matthew Perrone and Michelle L. Price contributed to this report.
Sierra Smith holds her son Travis, 2, during an event on health care affordability with President Donald Trump, and others, in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
Centers for Medicare & Medicaid Services administrator Dr. Mehmet Oz speaks speaks during an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump and Commerce Secretary Howard Lutnick listen during an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
Travis Smith, 2, crawls on the floor as President Donald Trump speaks during an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
President Donald Trump speaks during an event on health care affordability in the Oval Office at the White House, Thursday, April 23, 2026, in Washington. (AP Photo/Mark Schiefelbein)
Health and Human Services Secretary Robert F. Kennedy Jr. testifies before a Senate Committee on Finance hearing on Capitol Hill, Wednesday, April 22, 2026, in Washington. (AP Photo/Jose Luis Magana)
President Donald Trump speaks during an event for NCAA national champions in the State Dining Room of the White House, Tuesday, April 21, 2026, in Washington. (AP Photo/Alex Brandon)
